Viewing Study NCT00394056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-03-31 @ 8:54 AM
Study NCT ID: NCT00394056
Status: COMPLETED
Last Update Posted: 2016-10-28
First Post: 2006-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tinnitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None placebo View
None balanced View
None paroxetine View
None repeated dose View
None Hearing Loss View
None loudness View
None combination View
None Tinnitus View
None vestipitant (GW597599) View
None randomised View
None annoyance View
None crossover View